CFDE Data Portal | Search TBC1D17

	Label	Description
	TBC1D17 associations Collection (Entity type)	Associations for TBC1D17_associations
	TBC1D17 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	TBC1D17 Gene (Entity type)	ENSG00000104946 - TBC1 domain family member 17
	KFGENEBIN:TBC1D17-variant-count CUI gene has variants TBC1D17 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Kids First
	GSE239844 crizotinib 6 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE193351 ruxolitinib 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE197555 0 V 3 TRAMETINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE238213 dopamine 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE95077 1 V 2 AMILORIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE184210 0 V 1 GLUCAGON MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS

TBC1D17 associations

Associations for TBC1D17_associations

TBC1D17 associations.tsv

A file from IDG as part of the Harmonizome project

TBC1D17

ENSG00000104946 - TBC1 domain family member 17

KFGENEBIN:TBC1D17-variant-count CUI gene has variants TBC1D17

A Knowledge Graph Assertion from Kids First

GSE239844 crizotinib 6 v 9 human up

A Gene Set from LINCS

GSE193351 ruxolitinib 1 v 2 human dn

A Gene Set from LINCS

GSE197555 0 V 3 TRAMETINIB HUMAN UP

A Gene Set from LINCS

GSE238213 dopamine 1 v 0 human dn

A Gene Set from LINCS

GSE95077 1 V 2 AMILORIDE HUMAN DN

A Gene Set from LINCS

GSE184210 0 V 1 GLUCAGON MOUSE UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.